Treatment-induced mucositis in oncology

Area of Science:

• Oncology
• Cancer Therapeutics
• Patient Care

Background:

• Cancer therapies, including chemotherapy and radiotherapy, frequently cause severe side effects.
• Mucositis, an inflammation of mucous membranes, affects 20-40% of chemotherapy patients and 80% of head and neck cancer patients undergoing radiotherapy.
• This complication significantly impacts patient quality of life and complicates cancer treatment.

Purpose of the Study:

• To provide a comprehensive overview of current treatment modalities for managing cancer therapy-induced mucositis.
• To highlight the challenges in preventing and treating mucositis due to limited therapeutic options.
• To emphasize the importance of a multidisciplinary approach in mucositis management.

Main Methods:

• Review of existing literature on mucositis management strategies.
• Discussion of key components of a multidisciplinary approach: pain control, oral hygiene, nutritional support, and infection management.
• Analysis of the impact of mucositis on patient outcomes and cancer treatment.

Main Results:

• Mucositis is a common and debilitating side effect of cancer treatments.
• Effective management relies on a coordinated, multidisciplinary strategy.
• Current therapeutic options for prevention and treatment remain limited, posing clinical challenges.

Conclusions:

• A multidisciplinary approach is crucial for managing mucositis, focusing on symptom control and supportive care.
• The scarcity of effective treatments underscores the need for further research and development.
• Addressing mucositis is vital for improving patient quality of life and ensuring successful cancer treatment outcomes.